These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 37227302)
1. NH125 Sensitizes Staphylococcus aureus to Cell Wall-Targeting Antibiotics through the Inhibition of the VraS Sensor Histidine Kinase. Bhattarai S; Marsh L; Knight K; Ali L; Gomez A; Sunderhaus A; Abdel Aziz MH Microbiol Spectr; 2023 Jun; 11(3):e0486122. PubMed ID: 37227302 [TBL] [Abstract][Full Text] [Related]
2. The dimerization interface in VraR is essential for induction of the cell wall stress response in Staphylococcus aureus: a potential druggable target. Tajbakhsh G; Golemi-Kotra D BMC Microbiol; 2019 Jul; 19(1):153. PubMed ID: 31277575 [TBL] [Abstract][Full Text] [Related]
3. Site-specific mutation of Staphylococcus aureus VraS reveals a crucial role for the VraR-VraS sensor in the emergence of glycopeptide resistance. Galbusera E; Renzoni A; Andrey DO; Monod A; Barras C; Tortora P; Polissi A; Kelley WL Antimicrob Agents Chemother; 2011 Mar; 55(3):1008-20. PubMed ID: 21173175 [TBL] [Abstract][Full Text] [Related]
4. A close-up view of the VraSR two-component system. A mediator of Staphylococcus aureus response to cell wall damage. Belcheva A; Golemi-Kotra D J Biol Chem; 2008 May; 283(18):12354-64. PubMed ID: 18326495 [TBL] [Abstract][Full Text] [Related]
5. The Role of β-Glycosylated Wall Teichoic Acids in the Reduction of Vancomycin Susceptibility in Vancomycin-Intermediate Staphylococcus aureus. Hort M; Bertsche U; Nozinovic S; Dietrich A; Schrötter AS; Mildenberger L; Axtmann K; Berscheid A; Bierbaum G Microbiol Spectr; 2021 Oct; 9(2):e0052821. PubMed ID: 34668723 [TBL] [Abstract][Full Text] [Related]
6. The VraS/VraR two-component regulatory system required for oxacillin resistance in community-acquired methicillin-resistant Staphylococcus aureus. Boyle-Vavra S; Yin S; Daum RS FEMS Microbiol Lett; 2006 Sep; 262(2):163-71. PubMed ID: 16923071 [TBL] [Abstract][Full Text] [Related]
7. Revisiting the Role of VraTSR in Fernandes PB; Reed P; Monteiro JM; Pinho MG J Bacteriol; 2022 Aug; 204(8):e0016222. PubMed ID: 35862765 [TBL] [Abstract][Full Text] [Related]
9. VraT/YvqF is required for methicillin resistance and activation of the VraSR regulon in Staphylococcus aureus. Boyle-Vavra S; Yin S; Jo DS; Montgomery CP; Daum RS Antimicrob Agents Chemother; 2013 Jan; 57(1):83-95. PubMed ID: 23070169 [TBL] [Abstract][Full Text] [Related]
10. Genetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF/VraSR. Kato Y; Suzuki T; Ida T; Maebashi K J Antimicrob Chemother; 2010 Jan; 65(1):37-45. PubMed ID: 19889788 [TBL] [Abstract][Full Text] [Related]
11. Mutational analyses of open reading frames within the vraSR operon and their roles in the cell wall stress response of Staphylococcus aureus. McCallum N; Meier PS; Heusser R; Berger-Bächi B Antimicrob Agents Chemother; 2011 Apr; 55(4):1391-402. PubMed ID: 21220524 [TBL] [Abstract][Full Text] [Related]
12. VraSR two-component regulatory system and its role in induction of pbp2 and vraSR expression by cell wall antimicrobials in Staphylococcus aureus. Yin S; Daum RS; Boyle-Vavra S Antimicrob Agents Chemother; 2006 Jan; 50(1):336-43. PubMed ID: 16377706 [TBL] [Abstract][Full Text] [Related]
13. Role of VraSR in antibiotic resistance and antibiotic-induced stress response in Staphylococcus aureus. Gardete S; Wu SW; Gill S; Tomasz A Antimicrob Agents Chemother; 2006 Oct; 50(10):3424-34. PubMed ID: 17005825 [TBL] [Abstract][Full Text] [Related]
14. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Kuroda M; Kuroda H; Oshima T; Takeuchi F; Mori H; Hiramatsu K Mol Microbiol; 2003 Aug; 49(3):807-21. PubMed ID: 12864861 [TBL] [Abstract][Full Text] [Related]
15. Induction kinetics of the Staphylococcus aureus cell wall stress stimulon in response to different cell wall active antibiotics. Dengler V; Meier PS; Heusser R; Berger-Bächi B; McCallum N BMC Microbiol; 2011 Jan; 11():16. PubMed ID: 21251258 [TBL] [Abstract][Full Text] [Related]
16. Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem. Katayama Y; Murakami-Kuroda H; Cui L; Hiramatsu K Antimicrob Agents Chemother; 2009 Aug; 53(8):3190-6. PubMed ID: 19451283 [TBL] [Abstract][Full Text] [Related]
17. Detection of vancomycin nonsusceptible strains in clinical isolates of Staphylococcus aureus in northern Iran. Asadpour L; Ghazanfari N Int Microbiol; 2019 Dec; 22(4):411-417. PubMed ID: 30811005 [TBL] [Abstract][Full Text] [Related]
18. VraR Binding to the Promoter Region of Dai Y; Chang W; Zhao C; Peng J; Xu L; Lu H; Zhou S; Ma X Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289032 [TBL] [Abstract][Full Text] [Related]
19. Generation of a vancomycin-intermediate Staphylococcus aureus (VISA) strain by two amino acid exchanges in VraS. Berscheid A; François P; Strittmatter A; Gottschalk G; Schrenzel J; Sass P; Bierbaum G J Antimicrob Chemother; 2014 Dec; 69(12):3190-8. PubMed ID: 25103491 [TBL] [Abstract][Full Text] [Related]